Know the options for your patients
Discover and access clinical trials and expanded access programs quickly, using state-of-the-art search technology.
Discover and access clinical trials and expanded access programs quickly, using state-of-the-art search technology.
Discover how our platform can connect physicians and their patients to recruiting trial sites or support expanded access requests.
Enter pseudonymized patient data to search for eligible clinical trials and review potential options. Explore the latest published trial clinical information to support informed decision-making and make quick trial site referrals from our portal at the click of a button.
Simplify the submission and tracking of expanded access requests. Upload relevant patient documents securely and navigate the expanded access program process through our user-friendly platform.
Our user-friendly platform enables patients, physicians and trial sites to connect, reducing admin work and wait time and improving transparency throughout the process.
We help treating physicians and their teams identify clinical trials and expanded access programs using efficient, state-of-the-art technology. Through our platform, physicians can refer a patient to a clinical trial, and we support them to directly get in contact with a trial site. When clinical trials are not an option for patients, our dedicated and medically trained site managers can ensure personalized support in the process of ordering a drug under an expanded access program.
Whether patients qualify for clinical trials or need expanded access pathways, our free services provide comprehensive assistance throughout the patient journey.
We also support healthcare professionals in clinical research settings to receive high-quality patient referrals to their trials.
myTomorrows supports treating physicians with efficient, state-of-the-art technology for identifying clinical trials and expanded access programs. Via our platform, physicians can refer a patient to a clinical trial, and we support them to directly get in contact with a trial site.
When applicable, our dedicated and medically trained site managers assist physicians in this process of ordering a drug under an expanded access program, ensuring personalized support.
Whether patients qualify for EAPs or clinical trials, our free services provide comprehensive assistance throughout the patient journey.
Learn more about our services to treating physicians.
We empower patients and their physicians by offering a comprehensive overview on available options, whether it’s participating in a clinical trial or considering an expanded access program.
Patients receive equal support – with a global reach, we provide referrals to trial sites and can support physicians with the expanded access application processes worldwide. To guide patients through this intricate process, our patient navigators act as a single point of contact throughout their entire journey. Learn more about how we help patients.
We are dedicated to removing practical barriers for patients and physicians. That’s why our services are always provided free of charge; they include:
We charge BioPharma companies for our services, which include supporting clinical trial recruitment and managing international expanded access programs, logistics, quality management, distribution, and real-world data collection.
For physicians and their patients, myTomorrows ensures free and agnostic access to information about all potential pre-approval options, regardless of our collaborations with BioPharma companies.
If you have a problem or concern about any of the products that are shipped or distributed via myTomorrows, we would like to hear from you. Please send an email to quality@mytomorrows.com.
myTomorrows has a regulatory responsibility to monitor the safety of drugs prescribed through its programs. To report an adverse event or adverse drug reaction, please send an email to safety@mytomorrows.com.
We treat all patient data highly confidentially and none is processed without your/their explicit consent. Our strict data policy restricts access to data to only qualified employees with direct operational responsibility for helping patients, and our platform and all our digital solutions are fully GDPR-compliant and ISO-27001 certified. More information is available in our privacy and cookie statements.
Do you have a question around data privacy, data processing, or data protection? Please reach out to dataprotection@mytomorrows.com.
The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.
However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options.
